PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer
Clinical trial NCT04176952 · TERMINATED
Trial details
- NCT number
- NCT04176952
- Sponsor
- Judith Dixon-Hughes
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-05
- Primary completion
- 2021-08-19
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.